The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Phase III Intergroup Study of Talc Poudrage vs Talc Slurry Sclerosis for Malignant Pleural Effusion
Open accessAbstract
Study objective To demonstrate the efficacy, safety, and appropriate mode of instillation of talc for sclerosis in treatment of malignant pleural effusions (MPEs).Design A prospective, randomized trial was designed to compare thoracoscopy with talc insufflation (TTI) to thoracostomy and talc slurry (TS) for patients with documented MPE.Measurements The primary end point was 30-day freedom from radiographic MPE recurrence among surviving patients whose lungs initially re-expanded > 90%. Morbidity, mortality, and quality of life were also assessed.Results Of 501 patients registered, those eligible were randomized to TTI (n = 242) or TS (n = 240). Patient demographics and primary malignancies were similar between study arms. Overall, there was no difference between study arms in the percentage of patients with successful 30-day outcomes (TTI, 78%; TS, 71%). However, the subgroup of patients with primary lung or breast cancer had higher success with TTI than with TS (82% vs 67%). Common morbidity included fever, dyspnea, and pain. Treatment-related mortality occurred in nine TTI patients and seven TS patients. Respiratory complications were more common following TTI than TS (14% vs 6%). Respiratory failure was observed in 4% of TS patients and 8% of TTI patients, accounting for five toxic deaths and six toxic deaths, respectively. Quality-of-life measurement demonstrated less fatigue with TTI than TS. Patient ratings of comfort and safety were also higher for TTI, but there were no differences on perceived value or convenience of the procedures.Conclusions Both methods of talc delivery are similar in efficacy; TTI may be better for patients with either a lung or breast primary. The etiology and incidence of respiratory complications from talc need further exploration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“thoracoscopic insufflation with talc ( poudrage) is more effective than talc slurry sclerosis [II, B] [145].”
From Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (2016) · cites this paper as [145]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., Haes, J. C. J. M. D., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.5.365 · Cited by 16,005
Self-citationChemical Pleurodesis for Malignant Pleural Effusions
Walker-Renard, P., Vaughan, L. M., & Sahn, S. A. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-1-199401010-00010 · Cited by 420
de Campos, J. R. M., Cardoso, P. F. G., Vargas, F. S., Werebe, E. D. C., Teixeira, L. R., Jatene, F. B., & Light, R. W. (2001) · CHEST Journal · doi:10.1378/chest.119.3.801 · Cited by 284
Talc Pleurodesis for the Treatment of Pneumothorax and Pleural Effusion
Kennedy, L., & Sahn, S. A. (1994) · CHEST Journal · doi:10.1378/chest.106.4.1215 · Cited by 262
Respiratory failure following talc pleurodesis
Rehse, D. H., Aye, R. W., & Florence, M. G. (1999) · The American Journal of Surgery · doi:10.1016/s0002-9610(99)00075-6 · Cited by 252
Kennedy, L., Rusch, V. W., Strange, C., Ginsberg, R. J., & Sahn, S. A. (1994) · CHEST Journal · doi:10.1378/chest.106.2.342 · Cited by 247
Thoracoscopic Talc Poudrage Pleurodesis for Malignant Effusions
Viallat, J. R., Rey, F., Astoul, P. J., & Boutin, C. (1996) · CHEST Journal · doi:10.1378/chest.110.6.1387 · Cited by 240
Adult respiratory distress syndrome following intrapleural instillation of talc
Rinaldo, J. E., Owens, G. R., & Rogers, R. M. (1983) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(19)37535-x · Cited by 221
Thoracoscopic Talc Insufflation Versus Talc Slurry for Symptomatic Malignant Pleural Effusion
Yim, A. P. C., Chan, A. T. �., Tak, W. L., Wan, I. Y. P., & Ho, J. K. (1996) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(96)00808-9 · Cited by 217
Predicting Survival in Patients With Recurrent Symptomatic Malignant Pleural Effusions
Burrows, C. M., Mathews, W. C., & Colt, H. G. (2000) · CHEST Journal · doi:10.1378/chest.117.1.73 · Cited by 203
Research works printed but not linked: 2
- 1958, West J Surg Obstet Gynecol, 66, 26
- Fleishman, 2002, Quality of life (QOL) advantage of sclerosis for malignant pleural effusion (MPE) via talc thoracoscopy over chest tube infusion of talc slurry: a Cancer and Leukemia Group B study [abstract], Proc Am Soc Clin Oncol, 21, 355a
Cited by
Sorted by citations
Items 201–300 of 577
Terra, R. M., Teixeira, L. R., Bibas, B. J., Pêgo‐Fernandes, P. M., Vargas, F. S., & Jatene, F. B. (2011) · Clinics · doi:10.1590/s1807-59322011000200005 · Cited by 18
“We observed trapped lung in 21% of our patients and other authors had also failed in identify such features before drainage and found 15 and 20% of patients with trapped lung.(4,15) In spite of the fact that such patients had been excluded from the pleurodesis trial, we followed them, and we have found some significan…”
Surgical and other invasive approaches to recurrent pleural effusion with malignant etiology
Neragi-Miandoab, S. (2008) · Supportive Care in Cancer · doi:10.1007/s00520-008-0405-5 · Cited by 18
“Talc Slurry 80 Dresler et al. [ 66 ] Less respiratory complications compared with insufflation”
BackgroundMethodInfluentialAbrão, F. C., Peixoto, R. D., de Abreu, I. R. L. B., Janini, M. C., Viana, G. G., de Oliveira, M. C., & Younes, R. N. (2016) · Journal of Surgical Oncology · doi:10.1002/jso.24168 · Cited by 18
“reported that 58/340 (17%) of the patients died within 30 days of trial entry (which only included patients with a predicted survival of >2 months) [7].”
BackgroundMalignant Pleural Effusion: A Multidisciplinary Approach
Pardessus, A., Rafecas, A., Porcel, J. M., Serra, P., Ferreiro, L., Botana‐Rial, M., Hernández, C. R., Brenes, J. M., Canales, L., Camacho, V., et al. (2024) · Open Respiratory Archives · doi:10.1016/j.opresp.2024.100349 · Cited by 18
Lumachi, F., Mazza, F., Ermani, M., Chiara, G. B., & Basso, S. M. M. (2012) · PubMed · Cited by 17
Invasive Palliative Interventions
Strasser, F., Blum, D., & Büche, D. (2010) · The Cancer Journal · doi:10.1097/ppo.0b013e3181f842b3 · Cited by 17
“(6) Goal of intervention needs to be clearly defined before the invasive intervention Strasser et al The Cancer Journal & Volume 16, Number 5, September/October 2010”
BackgroundInfluentialKheir, F. M., Shawwa, K., Alokla, K., Omballi, M., & Alraiyes, A. H. (2015) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000000197 · Cited by 17
“For instance, patients with poor performance status or life expectancy of less than 2 months were excluded from a large randomized trial comparing talc slurry to talc insufflations.(19) Conversely, TPC can still be considered for those patients who are too debilitated to undergo pleurodesis procedures and can still ex…”
BackgroundNoro, R., Kobayashi, K., Usuki, J., Yomota, M., Nishitsuji, M., Shimokawa, T., Ando, M., Hino, M., Hagiwara, K., Miyanaga, A., et al. (2020) · Thoracic Cancer · doi:10.1111/1759-7714.13472 · Cited by 17
Grindell, C., Tod, A., Bec, R., Wolstenholme, D., Bhatnagar, R., Sivakumar, P., Morley, A., Holme, J., Lyons, J., Ahmed, M., et al. (2020) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-020-01200-3 · Cited by 17
Chemical pleurodesis for malignant pleural effusion
Shouman, W., Elgazzar, A. E. M. M., Hussien, R. M., ElShaaray, M., & Light, R. W. (2012) · Egyptian Journal of Chest Diseases and Tuberculosis · doi:10.1016/j.ejcdt.2012.10.013 · Cited by 17
Contribution of positron emission tomography in pleural disease
Duysinx, B., Corhay, J. L., Larock, M.-P., Withofs, N., Bury, T., Hustinx, R., & Louis, R. E. (2010) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2009.12.003 · Cited by 17
Use of tunneled pleural catheters for outpatient treatment of malignant pleural effusions
Stather, D. R., & Tremblay, A. (2007) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e328121447d · Cited by 17
Alraiyes, A. H., Dhillon, S. S., Harris, K. N., Kaphle, U., & Kheir, F. M. (2016) · PLEURA · doi:10.1177/2373997516632752 · Cited by 16
“It is important to mention that one study used nongraded talc and contributed to majority of mortality rate.(46) Major complications such as empyema, 8 PLEURA”
BackgroundHuggins, J. T., Doelken, P., & Sahn, S. A. (2011) · Respirology · doi:10.1111/j.1440-1843.2011.02011.x · Cited by 16
Garske, L. A., Kunarajah, K., Zimmerman, P. V., Adams, L., & Stewart, I. B. (2018) · PLoS ONE · doi:10.1371/journal.pone.0202621 · Cited by 16
Horn, L., Eisenberg, R., Gius, D. R., Kimmelshue, K. N., Massion, P. P., Putnam, J. B., Robinson, C. G., & Carbone, D. P. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-2865-7.00072-2 · Cited by 16
Phenotyping malignant pleural effusions
Lui, M. M., Fitzgerald, D. B., & Lee, G. (2016) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000267 · Cited by 15
“The ‘lifetime’ success rate of talc pleurodesis in controlling fluid recurrence remain poor (60–75%) in large clinical trials, irrespective of talc delivery by thoracoscopic poudrage or bedside slurry [8,36,55,56].”
BackgroundTreatment of malignant pleural effusion
Terra, R. M., & Vega, A. J. M. D. (2018) · Journal of Visualized Surgery · doi:10.21037/jovs.2018.05.02 · Cited by 15
“The tube is subsequently clamped for 1–2 hours (5,19).”
BackgroundResultAbrão, F. C., de Abreu, I. R. L. B., Fogarolli, M., Caxeiro, G. L., Bezerra, C. B. S., Cesar, F. P. D. C., Rocha, P. S., & Younes, R. N. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4491-6 · Cited by 15
“reported 17 % of mortality at 30 days.(19) We conclude that the primary site, anemia, leukocytosis, and low protein concentration in pleural fluid are associated with 30-day mortality in patients with MPE submitted to the first pleural palliative procedure.”
BackgroundManagement of Pleural Space: Effusions and Empyema
Christie, N. A. (2010) · Surgical Clinics of North America · doi:10.1016/j.suc.2010.07.003 · Cited by 15
Mitchell, M. A., Burkett, A., Pen, L., Zhang, T., & Amjadi, K. (2018) · Respiration · doi:10.1159/000491097 · Cited by 15
Grosu, H. B., Kern, R. M., Maldonado, F., Casal, R. F., Andersen, C. R., Li, L., Eapen, G. A., Ost, D. E., Jimenez, C., Frangopoulos, F., et al. (2022) · Respirology · doi:10.1111/resp.14232 · Cited by 15
“The decision to proceed directly to pleurodesis or further diagnostic procedures at the time of pleuroscopy requires a high degree of confidence in the on-site diagnosis.(5) The primary objective of this study was to create a predictive model for estimating the probability of MPEs during diagnostic pleuroscopy.”
BackgroundPredictors of lung entrapment in malignant pleural effusion
Trovisco, R. A., Freitas, C., Serino, M., Ferreira, P. M., Martins, B., Coelho, D. B., MELO, N., Fernandes, G., Magalhães, A., & Bastos, H. N. (2022) · Pulmonology · doi:10.1016/j.pulmoe.2022.08.001 · Cited by 14
“16 Given the inconsistency of NEL de fi nition across studies, we decided to apply a more clinically oriented criterion, considering the recommendations to attempt a pleurodesis whenever (cid:1) 50% of visceral and parietal pleura are apposed.”
Castaldo, N., Fantin, A., Palou, M. S., Viterale, G., Crisafulli, E., Sartori, G., Aujayeb, A., Patrucco, F., & Patruno, V. (2024) · Breathe · doi:10.1183/20734735.0002-2024 · Cited by 16
“[17] demonstrated a comparable success rate in fluid control at 30 days between thoracoscopic talc poudrage and talc slurry pleurodesis (78% versus 71%, respectively).”
BackgroundMalignant Pleural Effusion: Diagnosis and Treatment—Up-to-Date Perspective
Orlandi, R., Cara, A., Cassina, E. M., Degiovanni, S., Libretti, L., Pirondini, E., Raveglia, F., Tuoro, A., Vaquer, S., Rizzo, S., et al. (2024) · Current Oncology · doi:10.3390/curroncol31110507 · Cited by 14
“Randomized clinical trials have not demonstrated Chest tube insu ffl ation can be performed at the bedside with analgesia, while thoracoscopy requires general anesthesia or conscious sedation. a clear advantage of one technique over the other [63,64].”
Advances in Pleural Disease Management Including Updated Procedural Coding
Haas, A. R., & Sterman, D. H. (2014) · CHEST Journal · doi:10.1378/chest.13-2250 · Cited by 14
Karampinis, I., Dionysopoulou, A., Galata, C. L., Almstedt, K., Grilli, M., Hasenburg, A., & Roessner, E. D. (2022) · Thoracic Cancer · doi:10.1111/1759-7714.14361 · Cited by 14
“1% is inferior to other forms of surgical pleurodesis, such as talc pleurodesis in patients with metastatic breast cancer.(26) It is therefore reasonable to suggest the use of talc in case only pleurodesis is attempted.”
BackgroundAdams, J., Auger, J., & Schiff, D. E. (2014) · Pediatric Blood & Cancer · doi:10.1002/pbc.24919 · Cited by 14
“Furthermore, concerns have been raised about risk of ARD, respiratory failure, and death following talc administration [11,12].”
BackgroundYoneda, K. Y., Mathur, P. N., & Gasparini, S. (2007) · Clinical Lung Cancer · doi:10.3816/clc.2007.n.040 · Cited by 14
The Prevention of Carboxymethylcellulose on Bowel Adhesions Induced by Talc Peritonitis in Mice
Tanaka, K., Hashimoto, H., Misawa, T., & Akiba, T. (2018) · Journal of Surgical Research · doi:10.1016/j.jss.2018.10.008 · Cited by 14
Talc pleurodesis and acute respiratory distress syndrome
Aelony, Y. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60685-0 · Cited by 14
Marchi, E., Vargas, F. S., Madaloso, B. A., de Carvalho, M. V. H., Terra, R. M., & Teixeira, L. R. (2010) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37132010000600014 · Cited by 14
“Pleurodesis agent employed Talc 2-5 g 79 (58)* 24 (43)* 11 (30)* 149 No defined dose 24 (18) 6 (10) 5 (13) Total 103 (76)** 30 (53) 16 (43) Non-talc Tetracycline 19 (14)*** 13 (23)*** 4 (11) 81 Silver nitrate 8 (6) 0 (0) 0 (0) Iodopovidone 1 (1) 5 (9) 10 (27)*** Other 5 (3) 9 (15) 7 (9) Total 33 (24) 27 (47) 21 (57) O…”
MethodResultInfluentialPermanent Indwelling Catheters in the Management of Pleural Effusions
Gillen, J. R., & Lau, C. L. (2012) · Thoracic surgery clinics/Thorac. surg. clin. · doi:10.1016/j.thorsurg.2012.10.005 · Cited by 13
The role of pleurodesis in respiratory diseases
Mercer, R., Hassan, M., & Rahman, N. M. (2018) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2018.1445971 · Cited by 13
“Historically pleurodesis success was measured using radiological criteria such as no evidence of fluid recurrence on a chest radiograph [9].”
MethodResultPleurodesis: A novel experimental model
Marchi, E., Vargas, F. S., Acencio, M. M. P., Teixeira, L. R., Antonângelo, L., Lee, G., & Light, R. W. (2007) · Respirology · doi:10.1111/j.1440-1843.2007.01100.x · Cited by 13
Natural History of Asymptomatic Pleural Effusions in Lung Cancer Patients
Tremblay, A., Robbins, S., Berthiaume, L. R., & Michaud, G. C. (2007) · Journal of Bronchology · doi:10.1097/lbr.0b013e31804f5aa6 · Cited by 13
Clinical Outcomes and Health-Related Quality of Life after Thoracoscopic Talc Pleurodesis
Schniewind, B., Rose, T., Woltmann, N., Walter, J., Becker, T., Dohrmann, P., Küchler, T., & Kurdow, R. (2012) · Journal of Palliative Medicine · doi:10.1089/jpm.2011.0149 · Cited by 13
Gilbert, C. R., Furman, B. R., Feller-Kopman, D. J., & Haouzi, P. A. (2017) · Journal of Bronchology & Interventional Pulmonology · doi:10.1097/lbr.0000000000000420 · Cited by 13
Recent developments in pleurodesis for malignant pleural disease
Guinde, J., Georges, S., Bourinet, V., Laroumagne, S., Dutau, H. L., & Astoul, P. J. (2018) · The Clinical Respiratory Journal · doi:10.1111/crj.12958 · Cited by 13
Management of Malignant Pleural Effusions
Shafiq, M., & Feller-Kopman, D. J. (2020) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2020.02.009 · Cited by 13
A Review of Medical Thoracoscopy and Its Role in Management of Malignant Pleural Effusion
Gioia, M., & Arancibia, R. (2024) · Journal of Respiration · doi:10.3390/jor4010004 · Cited by 12
“In other instances, if the lung is not expandable due to entrapment/trapped lung, then an indwelling pleural catheter placement can be performed.”
Pleurodese: técnica e indicações
Vaz, M. C., Marchi, E., & Vargas, F. S. (2006) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37132006000400014 · Cited by 12
Predictors of talc slurry pleurodesis success in patients with malignant pleural effusions
Santos, P. S., Marques, M., Cruz, C., Monteiro, H. J., & Fradinho, F. (2017) · Revista Portuguesa de Pneumologia · doi:10.1016/j.rppnen.2017.01.008 · Cited by 12
Advantages of indwelling pleural catheters for management of malignant pleural effusions
Boshuizen, R. C., Thomas, R., & Lee, G. (2013) · Current Respiratory Care Reports · doi:10.1007/s13665-013-0042-4 · Cited by 12
Pleural effusions and pneumothorax: Beyond simple plumbing
Thomas, R., Rahman, N. M., Maskell, N. A., & Lee, G. (2020) · Respirology · doi:10.1111/resp.13881 · Cited by 12
Friedberg, J. S., & Cengel, K. A. (2010) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2010.01.009 · Cited by 12
Pleurodesis in follow-up and treatment of malignant pleural mesothelioma patients.
Ak, G., Metintaş, M., Yıldırım, H., Metintaş, S., Dündar, E., Erginel, S., & Alataş, F. (2009) · PubMed · Cited by 12
Lung, Chest Wall, Pleura, and Mediastinum
Putnam, J. B. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1560-6.00058-5 · Cited by 12
Malignant Pleural Effusions: Fixing the Leaky Faucet
Lee, G., & Wilkosz, S. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200804-616ed · Cited by 12
Fantin, A., Castaldo, N., Palou, M. S., Viterale, G., Crisafulli, E., Sartori, G., Patrucco, F., Vailati, P., Morana, G., Mei, F., et al. (2024) · Journal of Thoracic Disease · doi:10.21037/jtd-23-1745 · Cited by 12
“These findings align with a previous prospective randomized trial by Dresler et al. comparing TP with talc slurry, which found no significant difference in success rate at 30 days (78% vs. 71%, respectively) (71).”
Lee, P., & Mathur, P. N. (2016) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000265 · Cited by 11
“69% mortality and a major contribution (nine deaths of 16) was from a large randomized study conducted in the United States using nongraded talc [35,59].”
BackgroundNohara, K., Takada, K., Kojima, E., Ninomiya, K., Miyamatsu, S., Shimizu, T., Sakurai, T., Mizuno, T., & Yamashita, Y. (2016) · Respiratory Investigation · doi:10.1016/j.resinv.2016.04.005 · Cited by 11
Talc-induced Interstitial Pneumonitis with Respiratory Failure
Griffo, S., Musumeci, A. G., Luca, G. D., Saccenti, A., Grande, L. M., & Stassano, P. (2009) · Anaesthesia and Intensive Care · doi:10.1177/0310057x0903700114 · Cited by 11
Surgical Management of Metastatic Peritoneal or Pleural Disease
Gushchin, V., Demmy, T. L., & Kane, J. M. (2007) · Seminars in Oncology · doi:10.1053/j.seminoncol.2007.03.009 · Cited by 11
Dikensoy, Ö., Zhu, Z., Donnelly, E. F., Stathopoulos, G. T., Lane, K. B., & Light, R. W. (2005) · CHEST Journal · doi:10.1378/chest.128.5.3735 · Cited by 11
Özkul, S., Turna, A., Demirkaya, A., Aksoy, B., & Kaynak, K. (2014) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2072-1439.2014.11.31 · Cited by 10
“We did not use tunnelled catheter and thoracoscopy and we utilized talc-slurry which has been proved to be equally effective (12).”
MethodAkram, M. J., Khalid, U., Ashraf, M. B., Bakar, M. A., Butt, F. M., & Khan, F. (2020) · Annals of Thoracic Medicine · doi:10.4103/atm.atm_289_20 · Cited by 10
“[5,8] The success rate of talc pleurodesis, however, is low in patients with longer survival time.[9] Talc can be re‐administered after failed pleurodesis, but IPC is an innovative treatment alternative in patients with failed pleurodesis and trap lung.”
BackgroundRole of Interventional Radiology in Pediatric Cancer Patients
Aguado, A. (2022) · Current Oncology Reports · doi:10.1007/s11912-022-01320-1 · Cited by 10
Grosu, H. B., Vial, M. R., Vakil, E., Casal, R. F., Eapen, G. A., Morice, R. C., Stewart, J., Sarkiss, M. G., & Ost, D. E. (2017) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201701-056oc · Cited by 10
Management of Malignant Lung Entrapment, the Oncothorax
Petrov, R. V., Bakhos, C. T., & Abbas, A. E. (2017) · Thoracic surgery clinics/Thorac. surg. clin. · doi:10.1016/j.thorsurg.2017.08.009 · Cited by 10
Manometry performed at indwelling pleural catheter insertion to predict unexpandable lung
Halford, P., Bhatnagar, R., White, P., Haris, M., Harrison, R. N., Holme, J., Sivasothy, P. R., West, A., Bishop, L. J., Stanton, A. E., et al. (2020) · Journal of Thoracic Disease · doi:10.21037/jtd.2020.02.25 · Cited by 10
“These reasons may cause the poor inter-observer correlation seen when assessing radiographs for UL (23) and the varied rates of UL post-drainage in previous studies, which often use different diagnostic criteria of UL (24,25).”
BackgroundPostoperative outcome after palliative treatment of malignant pleural effusion
Markowiak, T., Ried, M., Großer, C., Hofmann, H., Hillejan, L., Hecker, E., Semik, M., Lesser, T., Kügler, C., Seifert, S., et al. (2022) · Thoracic Cancer · doi:10.1111/1759-7714.14534 · Cited by 10
“Either intervention can be performed via VATS, but the IPC can also be implanted under local anesthesia if thoracoscopy/pleural biopsy is not required, while the application of talc slurry via a chest drain has shown significantly worse results when compared to VATS.(15,16) Another benefit of the IPC is that it can be…”
ResultMatsubara, N., Itoh, K., Mukai, H., & Nagai, S. (2011) · International Journal of Clinical Oncology · doi:10.1007/s10147-011-0312-5 · Cited by 11
“5%) in our analysis was lower than those of previous studies, in which success rates ranged from 71 to 100% [9, 11, 12, 17].”
BackgroundResultTrends in Pleural Effusion Research
Bielsa, S., & Porcel, J. M. (2016) · PLEURA · doi:10.1177/2373997516646555 · Cited by 10
Palliation of thoracic malignancies
Gasper, W. J., Jamshidi, R., & Theodore, P. R. (2007) · Surgical Oncology · doi:10.1016/j.suronc.2007.08.009 · Cited by 9
“To more accurately compare the effectiveness of talc poudrage versus talc slurry, there have been three randomized prospective trials, all of which have shown similar efficacy for both treatments [13–15].”
BackgroundResultManagement of malignant pleural effusions
Dipper, A., Bhatnagar, R., & Maskell, N. A. (2020) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000685 · Cited by 9
“However, limitations such as talc delivery under general anaesthetic, radiological rather than clinical markers of pleurodesis success and use of mixed particle rather than graded talc reduce applicability of these results to current clinical practice [9,10,11].”
BackgroundDíaz, J. L. R., Almánzar, S. F., Muñoz, C. G., Lázaro, J., López-Porras, M., Márquez-Medina, D., Vicuña, M. N., Moreno, L., González-Cantalejo, M., & Porcel, J. M. (2022) · Cirugía Española (English Edition) · doi:10.1016/j.cireng.2022.06.009 · Cited by 9
Small-bore catheter is more than an alternative to the ordinary chest tube for pleural drainage
Hamad, A.-M. M., & Alfeky, S. E. (2020) · Lung India · doi:10.4103/lungindia.lungindia_44_20 · Cited by 9
Interventional Pulmonologist Perspective: Treatment of Malignant Pleural Effusion
Sweatt, A. J., & Sung, A. W. (2014) · Current Treatment Options in Oncology · doi:10.1007/s11864-014-0312-6 · Cited by 9
“In a recent meta-analysis [76••], comprised of the aforementioned talc slurry versus poudrage studies [31, 55, 73, 75], thoracoscopic pleurodesis was marginally favored to a similar magnitude as the prior Cochrane review (RR pleurodesis success 1.”
BackgroundResultInfluentialTeixeira, L. R., Pinto, J. A. F., & Marchi, E. (2006) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37132006000900004 · Cited by 9
Chirurgische Therapie des malignen Pleuraergusses
Ludwig, C., & Stoelben, E. (2008) · Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie · doi:10.1055/s-2008-1076788 · Cited by 9
Tunneled Pleural Catheters for Palliation of Malignant Pleural Effusions
Michaud, G. T., Barclay, P., & Tremblay, A. (2005) · Journal of Bronchology · doi:10.1097/01.lab.0000185782.99433.02 · Cited by 9
Pleurodesis for recurrent malignant pleural effusions: the quest for the Holy Grail
Astoul, P. J. (2010) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2010.11.035 · Cited by 9
“[3] Dresler CM, Olak J, Herndon JE, Richards WG, Scalzetti E, Fleishman SB,”
BackgroundResultInfluentialUltrasound-Guided Percutaneous Biopsy to Diagnose Indwelling Pleural Catheter Metastasis
Riker, D., & Sell, R. (2012) · Journal of Bronchology & Interventional Pulmonology · doi:10.1097/lbr.0b013e3182517bba · Cited by 8
Endoscopic diagnosis and management of pleural effusion in malignant pleural mesothelioma
Ceruti, P., Lonni, S., Baglivo, F., & Marchetti, G. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2017.09.142 · Cited by 8
“9% saline) through a chest tube, or as “talc poudrage” (insufflation of sterile graded talc powder during MT or VATS), with substantial equivalence in efficacy (27,28).”
BackgroundSchwalk, A., & Ost, D. E. (2021) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2021.08.009 · Cited by 8
Verma, A., Taha, A., Venkateswaran, S., & Tee, A. (2015) · Singapore Medical Journal · doi:10.11622/smedj.2015075 · Cited by 8
“71%).(7) The purpose of the present study was to evaluate the effectiveness of MT in: (a) the diagnosis of indeterminate pleural effusion; and (b) pleurodesis by talc insufflation.”
BackgroundAdvances in the investigation and treatment of pleural effusions
Mishra, E. K., & Davies, R. J. O. (2010) · Expert Review of Respiratory Medicine · doi:10.1586/ers.09.67 · Cited by 8
Saka, H., Oki, M., Kitagawa, C., Kogure, Y., Kojima, Y., Saito, A. M., Ishida, A., Miyazawa, T., Takeda, K., Nakagawa, K., et al. (2018) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyy020 · Cited by 8
“Patients who satisfied the following criteria were excluded: (1) hypersensitivity to talc; (2) hypersensitivity to lidocaine hydrochloride; (3) concomitant serious infection; (4) advanced emphysema and/or fibrosis in the lungs; (5) current treatment for cardiac failure at the time of consent; (6) history of myocardial…”
BackgroundMethodPLEURAL EFFUSION: BENIGN AND MALIGNANT
Rusch, V. W. (2008) · Elsevier eBooks · doi:10.1016/b978-0-443-06861-4.50088-5 · Cited by 8
Alisky, J. M. (2007) · Medical Hypotheses · doi:10.1016/j.mehy.2006.04.081 · Cited by 8
Chemical Pleurodesis for Malignant Pleural Effusion: How Far Have We Come in 80 Years?
Koegelenberg, C. F. N., & Vorster, M. J. (2015) · Respiration · doi:10.1159/000441308 · Cited by 8
Management of malignant pleural effusions
Hsia, D. W., & Musani, A. I. (2012) · Current Respiratory Care Reports · doi:10.1007/s13665-012-0012-2 · Cited by 7
Tomorrow's Cancer Treatments Today: The First 50 Years of the Cancer and Leukemia Group B
Green, M. R., George, S. L., & Schilsky, R. L. (2008) · Seminars in Oncology · doi:10.1053/j.seminoncol.2008.07.002 · Cited by 7
Luks, V., Aljohaney, A. A., & Amjadi, K. (2013) · Respiration · doi:10.1159/000348274 · Cited by 7
Agrawal, A., & Murgu, S. D. (2020) · Journal of Thoracic Disease · doi:10.21037/jtd.2020.03.57 · Cited by 7
“At least 30% of the patients with MPE have a non-expandable lung (32).”
BackgroundDíaz, J. L. R., Almánzar, S. F., Muñoz, C. G., Sierra, J. L., López-Porras, M., Márquez-Medina, D., Vicuña, M. N., Moreno, L., González-Cantalejo, M., & Porcel, J. M. (2022) · Cirugía Española · doi:10.1016/j.ciresp.2022.05.005 · Cited by 7
Advances in the management of pleural disease
Corcoran, J. P., Hallifax, R., & Rahman, N. M. (2013) · Expert Review of Respiratory Medicine · doi:10.1586/17476348.2013.838016 · Cited by 7
Low-dose Talc Plus Low-dose Doxycycline for Pleuroscopic Pleurodesis
Abouzgheib, W. B., Bartter, T. C., Kanaan, R., & Rodman, D. (2009) · Journal of Bronchology & Interventional Pulmonology · doi:10.1097/lbr.0b013e31819e2f7b · Cited by 7
Risk factors related to pleural empyema after talc slurry pleurodesis
D’Ambrosio, P. D., de Araújo, P. H. X. N., Rocha, E., Filho, M. R., Pêgo‐Fernandes, P. M., & Terra, R. M. (2022) · Clinics · doi:10.1016/j.clinsp.2022.100098 · Cited by 7
Management of Malignant Pleural Effusions
Villanueva, A. G. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4292-9_64 · Cited by 7
Use of Tunneled Pleural Catheters in Malignant Mesothelioma
Tremblay, A., Patel, M., & Michaud, G. T. (2005) · Journal of Bronchology · doi:10.1097/01.laboratory.0000188644.81416.3c · Cited by 7
How Should We Manage Empyema Complicating Tunneled Pleural Catheter Placement?
Tremblay, A., Stather, D. R., & MacEachern, P. R. (2010) · Journal of Bronchology & Interventional Pulmonology · doi:10.1097/lbr.0b013e3181dab03d · Cited by 7
Indwelling Pleural Catheters for Ambulatory Out-Patient Care: A Price Worth Paying?
Bhatnagar, R., & Maskell, N. A. (2013) · Respiration · doi:10.1159/000354184 · Cited by 7
Systemic Inflammatory Response to Different Sclerosing Agents as a Predictor of Pleurodesis Outcome
Zablockis, R., Danila, E., Gruslys, V., & Cincilevičiūtė, G. (2021) · In Vivo · doi:10.21873/invivo.12516 · Cited by 6
Rodrigues, A. L. S. D. O., Souza, M. E. C., de Moraes, F. C. A., de Lima, D. P., & de Carvalho, R. L. C. (2024) · Jornal Brasileiro de Pneumologia · doi:10.36416/1806-3756/e20240115 · Cited by 6
“Similarly, Bhatnagar et al. (19) and Dresler et al. (21) concluded that both approaches are effective.”
BackgroundInfluentialHabal, P., Jankovičová, K., Omran, N., Kondělková, K., Krejsek, J., & Manďák, J. (2012) · Biomedical Papers · doi:10.5507/bp.2012.095 · Cited by 6
Echogenic Swirling Seen on Ultrasound and Outcome of Pleurodesis in Malignant Pleural Effusion
Hassan, M., Asciak, R., Mercer, R., McCracken, D. J., Tsikrika, S., Shaarawy, H. M., Elganady, A. A., Wrightson, J., & Rahman, N. M. (2019) · Archivos de Bronconeumología · doi:10.1016/j.arbr.2019.05.018 · Cited by 6
Medical thoracoscopy in 2020: essential and future techniques
Pinelli, V., & Clive, A. O. (2020) · European Respiratory Society eBooks · doi:10.1183/2312508x.10023519 · Cited by 6
The role of interventional therapy for pleural diseases
DePew, Z. S., & Maldonado, F. (2014) · Expert Review of Respiratory Medicine · doi:10.1586/17476348.2014.918852 · Cited by 6
“Malignant pleural effusions MPEs are effusions associated with a concurrent malignancy.”
BackgroundInfluential
Metadata
- Authors
- Dresler, C. M., Olak, J., Herndon, J. E., Richards, W. G., Scalzetti, E., Fleishman, S. B., Kernstine, K. H., Demmy, T., Jablons, D. M., Kohman, L., Daniel, T. M., Haasler, G. B., & Sugarbaker, D. J.
- Affiliations
- Centre international de recherche sur le cancer (FR)
- Advocate Lutheran General Hospital (US)
- Brigham and Women's Hospital (US)
- SUNY Upstate Medical University (US)
- University of Iowa (US)
- Roswell Park Comprehensive Cancer Center (US)
- University of California, San Francisco (US)
- University of Virginia Health System (US)
- Medical College of Wisconsin (US)
- Corresponding author
- Dresler, Carolyn M
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 2005-03
- Volume
- 127
- Issue
- 3
- Pages
- 909-915
- ISSN
- 0012-3692 (ISSN-L)
- PMC
- PMC4644736
- OpenAlex
- W2147481343
- Cited by
- 578
- References
- 39
- Citations by year
- 2026: 10 · 2025: 20 · 2024: 24 · 2023: 12 · 2022: 27 · 2021: 26 · 2020: 40 · 2019: 23 · 2018: 38 · 2017: 31 · 2016: 32 · 2015: 34 · 2014: 32 · 2013: 33 · 2012: 35
- FWCI
- 22.73
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- CHEST Journal (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (2 U01 CA65170, R01CA093708, U01CA065170)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pleural and Pulmonary Diseases
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Diagnosis and Treatment
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Pericarditis and Cardiac Tamponade
- Keywords
- malignant pleural effusion, talc poudrage, talc slurry, talc pleurodesis, thoracostomy, pleural effusion recurrence, respiratory complications, non-relapse mortality, quality of life, lung cancer, breast cancer
- MeSH terms
- Adult, Aged, Aged, 80 and over, Female, Humans, Insufflation, Male, Middle Aged, Quality of Life, Recurrence, Talc, Thoracoscopy, Thoracostomy, Pleural Effusion, Malignant, Pleurodesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
